Microglia In Batten Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
| Property |
Value |
| Category |
Immune Cells |
| Location |
Brain parenchyma |
| Cell Type |
Microglia |
| Key Markers |
Iba1, CD68, CD45 |
- Immune Surveillance: Constant brain monitoring
- Phagocytosis: Cellular debris removal
- Synaptic Pruning: Developmental remodeling
- Neuroinflammation: Cytokine release
- CLN gene mutations: Various forms (CLN1-14)
- Ceroid accumulation: Lipofuscins storage
- Autophagy defects: Protein clearance failure
- Lysosomal rupture: Enzyme release
- Chronic activation: Continuous inflammatory state
- Pro-inflammatory cytokines: IL-1β, TNF-α, IL-6
- Oxidative stress: ROS production
- Complement activation: Synaptic elimination
- Anti-inflammatory drugs: Minocycline trials
- Gene therapy: AAV vector delivery
- Enzyme replacement: For certain forms
- Stem cell therapy: Experimental approaches
- Seizures: Early progressive onset
- Vision loss: Retinal degeneration
- Motor decline: Ataxia and spasticity
- Cognitive regression: Developmental reversal
The study of Microglia In Batten Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Mole SE. Neuronal ceroid lipofuscinoses. Handb Clin Neurol. 2013.
- MacDonald M. Molecular genetics of Batten disease. J Inherit Metab Dis. 1995.